+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non Vascular Stent Market: Global Opportunity Analysis and Industry Forecast, 2024-2035

  • PDF Icon

    Report

  • 285 Pages
  • March 2025
  • Region: Global
  • Allied Market Research
  • ID: 6119963
Description Jump to:
The global non vascular stent market size was valued at $1.6 billion in 2023, and is estimated to reach $2.7 billion by 2035, growing at a CAGR of 4.5% from 2024 to 2035. Stents are tubular medical devices designed to keep passageways in the body open, typically used to treat obstructions or narrowing. They can be vascular, placed in blood vessels, or non vascular, used in lumens like the gastrointestinal, biliary, urinary, or respiratory tracts. Non vascular stents work by providing structural support to maintain patency in blocked or narrowed passages. They are deployed using minimally invasive techniques such as endoscopy or fluoroscopy and expand to the desired size, either through self-expansion or balloon dilation. Made from materials such as nitinol (a shape-memory alloy), stainless steel, polymers, or biodegradable substances, non vascular stents often feature coatings to reduce inflammation or prevent infection. These stents alleviate symptoms, improve organ function, and enhance quality of life.

Rise in aging population is one of the most significant drivers for the expansion of the non vascular stent market. According to the Population Reference Bureau (PRB), the number of Americans aged 65 and older is expected to increase from 58 million in 2022 to 82 million by 2050, marking a 47% rise. As the elderly population grows, the prevalence of age-related chronic diseases, such as gastrointestinal disorders, respiratory diseases, and cancers, also increases. These conditions often lead to obstructions in non vascular lumens, requiring stent placement to restore proper function and alleviate symptoms. Thus, demand for non vascular stents is expected to rise significantly as more elderly patients require these medical devices for effective treatment and symptom management.

In addition, rise in preference for minimally invasive procedures has played a critical role in driving market growth. Minimally invasive surgeries, such as stent placement, offer numerous benefits over traditional open surgeries, including shorter recovery times, reduced risk of complications, and improved patient comfort. These advantages make minimally invasive treatments highly attractive to both patients and healthcare providers, further accelerating the adoption of non vascular stents. The trend towards minimally invasive procedures is also fueled by rise in awareness of their benefits, encouraging patients to opt for less invasive alternatives for conditions such as biliary and gastrointestinal obstructions.

Moreover, technological innovation is contributing to the market growth by introducing advanced stent options that cater to a broader range of patient needs. Development of MRI-compatible stents has enhanced treatment options for patients who require magnetic resonance imaging (MRI) during their diagnosis or treatment. These MRI-compatible stents can withstand the magnetic field of MRI machines without compromising their functionality, making them suitable for a more extensive set of patients. As these technological advancements continue to improve, they will further contribute to the adoption and expansion of non vascular stents, addressing the evolving demands of the healthcare market and increasing patient outcomes. Thus, rise in aging population, rise in preference for minimally invasive options, and technological innovations drive the growth of the market.

The non vascular stent market is segmented into product type, material type, end user, and region. On the basis of product type, it is segmented into gastrointestinal stents, pulmonary (airway) stents, urological stents, and others. On the basis of material type, the market is classified into metallic stents, and non-metallic stents. On the basis of end user, it is classified into hospitals, ambulatory surgical centers, and others. On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include ELLA- CS, s.r.o., Boston Scientific Corporation, Hobbs Medical Inc., Becton, Dickinson & Company, W.L. Gore & Associate Inc., Medtronic Plc, MICRO-TECH (Nanjing) Co., Ltd., Q3 Medical Group, CONMED Corporation, and Cook Medical. The key players have adopted product approval as the key strategies for expansion of their product portfolio.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the non vascular stent market analysis from 2023 to 2035 to identify the prevailing non vascular stent market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the non vascular stent market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global non vascular stent market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario
  • SWOT Analysis
  • Volume Market Size and Forecast

Key Market Segments

By Material Type

  • Metallic Stents
  • Non metallic Stents

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Product Type

  • Gastrointestinal Stents
  • Pulmonary Stents
  • Urological Stents
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • ELLA - CS, s.r.o.
  • Becton, Dickinson, and Company
  • W.L. Gore & Associate Inc.
  • CONMED Corporation
  • Q3 Medical Group
  • Micro-tech (nanjing) Co., Ltd.
  • Hobbs Medical Inc.
  • Cook Group
  • Boston Scientific Corporation
  • Medtronic plc

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic diseases
3.4.1.2. Rise in preference for minimally invasive surgeries
3.4.1.3. Favorable Reimbursement Policies
3.4.2. Restraints
3.4.2.1. High Production Costs and Stringent Regulatory Requirements
3.4.3. Opportunities
3.4.3.1. Advancements in Material Technology
CHAPTER 4: NON VASCULAR STENT MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Gastrointestinal Stents
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Pulmonary Stents
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Urological Stents
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Others
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: NON VASCULAR STENT MARKET, BY MATERIAL TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Metallic Stents
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Non metallic Stents
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: NON VASCULAR STENT MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NON VASCULAR STENT MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Material Type
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product Type
7.2.5.1.2. Market size and forecast, by Material Type
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product Type
7.2.5.2.2. Market size and forecast, by Material Type
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product Type
7.2.5.3.2. Market size and forecast, by Material Type
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Material Type
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product Type
7.3.5.1.2. Market size and forecast, by Material Type
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product Type
7.3.5.2.2. Market size and forecast, by Material Type
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product Type
7.3.5.3.2. Market size and forecast, by Material Type
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product Type
7.3.5.4.2. Market size and forecast, by Material Type
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product Type
7.3.5.5.2. Market size and forecast, by Material Type
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product Type
7.3.5.6.2. Market size and forecast, by Material Type
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Material Type
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Product Type
7.4.5.1.2. Market size and forecast, by Material Type
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Product Type
7.4.5.2.2. Market size and forecast, by Material Type
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product Type
7.4.5.3.2. Market size and forecast, by Material Type
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Product Type
7.4.5.4.2. Market size and forecast, by Material Type
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product Type
7.4.5.5.2. Market size and forecast, by Material Type
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product Type
7.4.5.6.2. Market size and forecast, by Material Type
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Material Type
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product Type
7.5.5.1.2. Market size and forecast, by Material Type
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Product Type
7.5.5.2.2. Market size and forecast, by Material Type
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Product Type
7.5.5.3.2. Market size and forecast, by Material Type
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Product Type
7.5.5.4.2. Market size and forecast, by Material Type
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. ELLA - CS, s.r.o.
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Boston Scientific Corporation
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Hobbs Medical Inc.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. Becton, Dickinson, and Company
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. W.L. Gore & Associate Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Medtronic plc
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Cook Group
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Micro-tech (nanjing) Co., Ltd.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Q3 Medical Group
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Key strategic moves and developments
9.10. CONMED Corporation
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
LIST OF TABLES
Table 01. Global Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 02. Non Vascular Stent Market for Gastrointestinal Stents, by Region, 2023-2035 ($Million)
Table 03. Non Vascular Stent Market for Pulmonary Stents, by Region, 2023-2035 ($Million)
Table 04. Non Vascular Stent Market for Urological Stents, by Region, 2023-2035 ($Million)
Table 05. Non Vascular Stent Market for Others, by Region, 2023-2035 ($Million)
Table 06. Global Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 07. Non Vascular Stent Market for Metallic Stents, by Region, 2023-2035 ($Million)
Table 08. Non Vascular Stent Market for Non Metallic Stents, by Region, 2023-2035 ($Million)
Table 09. Global Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 10. Non Vascular Stent Market for Hospitals, by Region, 2023-2035 ($Million)
Table 11. Non Vascular Stent Market for Ambulatory Surgical Centers, by Region, 2023-2035 ($Million)
Table 12. Non Vascular Stent Market for Others, by Region, 2023-2035 ($Million)
Table 13. Non Vascular Stent Market, by Region, 2023-2035 ($Million)
Table 14. North America Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 15. North America Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 16. North America Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 17. North America Non Vascular Stent Market, by Country, 2023-2035 ($Million)
Table 18. U.S. Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 19. U.S. Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 20. U.S. Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 21. Canada Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 22. Canada Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 23. Canada Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 24. Mexico Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 25. Mexico Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 26. Mexico Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 27. Europe Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 28. Europe Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 29. Europe Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 30. Europe Non Vascular Stent Market, by Country, 2023-2035 ($Million)
Table 31. Germany Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 32. Germany Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 33. Germany Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 34. France Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 35. France Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 36. France Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 37. UK Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 38. UK Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 39. UK Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 40. Italy Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 41. Italy Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 42. Italy Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 43. Spain Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 44. Spain Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 45. Spain Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 46. Rest of Europe Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 47. Rest of Europe Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 48. Rest of Europe Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 49. Asia-Pacific Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 50. Asia-Pacific Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 51. Asia-Pacific Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 52. Asia-Pacific Non Vascular Stent Market, by Country, 2023-2035 ($Million)
Table 53. Japan Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 54. Japan Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 55. Japan Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 56. China Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 57. China Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 58. China Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 59. India Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 60. India Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 61. India Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 62. Australia Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 63. Australia Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 64. Australia Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 65. South Korea Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 66. South Korea Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 67. South Korea Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 68. Rest of Asia-Pacific Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 69. Rest of Asia-Pacific Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 70. Rest of Asia-Pacific Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 71. LAMEA Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 72. LAMEA Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 73. LAMEA Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 74. LAMEA Non Vascular Stent Market, by Country, 2023-2035 ($Million)
Table 75. Brazil Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 76. Brazil Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 77. Brazil Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 78. Saudi Arabia Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 79. Saudi Arabia Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 80. Saudi Arabia Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 81. South Africa Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 82. South Africa Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 83. South Africa Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 84. Rest of LAMEA Non Vascular Stent Market, by Product Type, 2023-2035 ($Million)
Table 85. Rest of LAMEA Non Vascular Stent Market, by Material Type, 2023-2035 ($Million)
Table 86. Rest of LAMEA Non Vascular Stent Market, by End-user, 2023-2035 ($Million)
Table 87. Ella - Cs, S.R.O.: Key Executives
Table 88. Ella - Cs, S.R.O.: Company Snapshot
Table 89. Ella - Cs, S.R.O.: Product Segments
Table 90. Ella - Cs, S.R.O.: Product Portfolio
Table 91. Boston Scientific Corporation: Key Executives
Table 92. Boston Scientific Corporation: Company Snapshot
Table 93. Boston Scientific Corporation: Product Segments
Table 94. Boston Scientific Corporation: Product Portfolio
Table 95. Hobbs Medical Inc.: Key Executives
Table 96. Hobbs Medical Inc.: Company Snapshot
Table 97. Hobbs Medical Inc.: Product Segments
Table 98. Hobbs Medical Inc.: Product Portfolio
Table 99. Becton, Dickinson, and Company: Key Executives
Table 100. Becton, Dickinson, and Company: Company Snapshot
Table 101. Becton, Dickinson, and Company: Product Segments
Table 102. Becton, Dickinson, and Company: Product Portfolio
Table 103. W.L. Gore & Associate Inc.: Key Executives
Table 104. W.L. Gore & Associate Inc.: Company Snapshot
Table 105. W.L. Gore & Associate Inc.: Product Segments
Table 106. W.L. Gore & Associate Inc.: Product Portfolio
Table 107. Medtronic plc: Key Executives
Table 108. Medtronic plc: Company Snapshot
Table 109. Medtronic plc: Product Segments
Table 110. Medtronic plc: Product Portfolio
Table 111. Cook Group: Key Executives
Table 112. Cook Group: Company Snapshot
Table 113. Cook Group: Product Segments
Table 114. Cook Group: Service Segments
Table 115. Cook Group: Product Portfolio
Table 116. Micro-Tech (Nanjing) Co., Ltd.: Key Executives
Table 117. Micro-Tech (Nanjing) Co., Ltd.: Company Snapshot
Table 118. Micro-Tech (Nanjing) Co., Ltd.: Product Segments
Table 119. Micro-Tech (Nanjing) Co., Ltd.: Product Portfolio
Table 120. Q3 Medical Group: Key Executives
Table 121. Q3 Medical Group: Company Snapshot
Table 122. Q3 Medical Group: Product Segments
Table 123. Q3 Medical Group: Product Portfolio
Table 124. Q3 Medical Group: Key Stratergies
Table 125. Conmed Corporation: Key Executives
Table 126. Conmed Corporation: Company Snapshot
Table 127. Conmed Corporation: Product Segments
Table 128. Conmed Corporation: Product Portfolio
LIST OF FIGURES
Figure 01. Non Vascular Stent Market, 2023-2035
Figure 02. Segmentation of Non Vascular Stent Market,2023-2035
Figure 03. Top Impacting Factors in Non Vascular Stent Market (2023 to 2035)
Figure 04. Top Investment Pockets in Non Vascular Stent Market (2024-2035)
Figure 05. Moderate Bargaining Power of Suppliers
Figure 06. Moderate Threat of New Entrants
Figure 07. Moderate Threat of Substitutes
Figure 08. Moderate Intensity of Rivalry
Figure 09. Moderate Bargaining Power of Buyers
Figure 10. Global Non Vascular Stent Market:Drivers, Restraints and Opportunities
Figure 11. Non Vascular Stent Market, by Product Type, 2023 and 2035(%)
Figure 12. Comparative Share Analysis of Non Vascular Stent Market for Gastrointestinal Stents, by Country 2023 and 2035(%)
Figure 13. Comparative Share Analysis of Non Vascular Stent Market for Pulmonary Stents, by Country 2023 and 2035(%)
Figure 14. Comparative Share Analysis of Non Vascular Stent Market for Urological Stents, by Country 2023 and 2035(%)
Figure 15. Comparative Share Analysis of Non Vascular Stent Market for Others, by Country 2023 and 2035(%)
Figure 16. Non Vascular Stent Market, by Material Type, 2023 and 2035(%)
Figure 17. Comparative Share Analysis of Non Vascular Stent Market for Metallic Stents, by Country 2023 and 2035(%)
Figure 18. Comparative Share Analysis of Non Vascular Stent Market for Non Metallic Stents, by Country 2023 and 2035(%)
Figure 19. Non Vascular Stent Market, by End-user, 2023 and 2035(%)
Figure 20. Comparative Share Analysis of Non Vascular Stent Market for Hospitals, by Country 2023 and 2035(%)
Figure 21. Comparative Share Analysis of Non Vascular Stent Market for Ambulatory Surgical Centers, by Country 2023 and 2035(%)
Figure 22. Comparative Share Analysis of Non Vascular Stent Market for Others, by Country 2023 and 2035(%)
Figure 23. Non Vascular Stent Market by Region, 2023 and 2035(%)
Figure 24. U.S. Non Vascular Stent Market, 2023-2035 ($Million)
Figure 25. Canada Non Vascular Stent Market, 2023-2035 ($Million)
Figure 26. Mexico Non Vascular Stent Market, 2023-2035 ($Million)
Figure 27. Germany Non Vascular Stent Market, 2023-2035 ($Million)
Figure 28. France Non Vascular Stent Market, 2023-2035 ($Million)
Figure 29. UK Non Vascular Stent Market, 2023-2035 ($Million)
Figure 30. Italy Non Vascular Stent Market, 2023-2035 ($Million)
Figure 31. Spain Non Vascular Stent Market, 2023-2035 ($Million)
Figure 32. Rest of Europe Non Vascular Stent Market, 2023-2035 ($Million)
Figure 33. Japan Non Vascular Stent Market, 2023-2035 ($Million)
Figure 34. China Non Vascular Stent Market, 2023-2035 ($Million)
Figure 35. India Non Vascular Stent Market, 2023-2035 ($Million)
Figure 36. Australia Non Vascular Stent Market, 2023-2035 ($Million)
Figure 37. South Korea Non Vascular Stent Market, 2023-2035 ($Million)
Figure 38. Rest of Asia-Pacific Non Vascular Stent Market, 2023-2035 ($Million)
Figure 39. Brazil Non Vascular Stent Market, 2023-2035 ($Million)
Figure 40. Saudi Arabia Non Vascular Stent Market, 2023-2035 ($Million)
Figure 41. South Africa Non Vascular Stent Market, 2023-2035 ($Million)
Figure 42. Rest of LAMEA Non Vascular Stent Market, 2023-2035 ($Million)
Figure 43. Top Winning Strategies, by Year (2021)
Figure 44. Top Winning Strategies, by Development (2021)
Figure 45. Top Winning Strategies, by Company (2021)
Figure 46. Product Mapping of Top 10 Players
Figure 47. Competitive Dashboard
Figure 48. Competitive Heatmap: Non Vascular Stent Market
Figure 49. Top Player Positioning, 2023
Figure 50. Boston Scientific Corporation: Net Sales, 2021-2023 ($Million)
Figure 51. Boston Scientific Corporation: Revenue Share by Segment, 2023 (%)
Figure 52. Boston Scientific Corporation: Revenue Share by Region, 2023 (%)
Figure 53. Becton, Dickinson, and Company: Net Revenue, 2021-2023 ($Million)
Figure 54. Becton, Dickinson, and Company: Revenue Share by Segment, 2023 (%)
Figure 55. Becton, Dickinson, and Company: Revenue Share by Region, 2023 (%)
Figure 56. Medtronic PLC: Net Sales, 2022-2024 ($Million)
Figure 57. Medtronic PLC: Revenue Share by Segment, 2024 (%)
Figure 58. Medtronic PLC: Revenue Share by Region, 2024 (%)
Figure 59. Conmed Corporation: Net Revenue, 2021-2023 ($Million)
Figure 60. Conmed Corporation: Revenue Share by Region, 2023 (%)

Companies Mentioned

  • ELLA – CS, s.r.o.
  • Becton, Dickinson, and Company
  • W.L. Gore & Associate Inc.
  • CONMED Corporation
  • Q3 Medical Group
  • Micro-tech (nanjing) Co., Ltd.
  • Hobbs Medical Inc.
  • Cook Group
  • Boston Scientific Corporation
  • Medtronic plc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages285
PublishedMarch 2025
Forecast Period2023 - 2035
Estimated Market Value ( USD ) in 2023 $ 1.6 billion
Forecasted Market Value ( USD ) by 2035 $ 2.7 billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Non-Vascular Stents - Global Strategic Business Report - Product Image

Non-Vascular Stents - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Non-vascular Stents Market by Application (Airway, Biliary, Gastrointestinal), Product Type (Balloon-Expandable, Self-Expanding), Material Type, End User - Global Forecast 2025-2030 - Product Image

Non-vascular Stents Market by Application (Airway, Biliary, Gastrointestinal), Product Type (Balloon-Expandable, Self-Expanding), Material Type, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Non-vascular Stent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Non-vascular Stent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 81 Pages
  • Global
From
Non-Vascular Stents Market Size, Share and Trends Analysis Report by Type (Gastrointestinal Stents, Duodenal, Colonic, Pulmonary (Airway) Stents, Urological Stents), End-use (Hospitals), and Region 2024-2030 - Product Image

Non-Vascular Stents Market Size, Share and Trends Analysis Report by Type (Gastrointestinal Stents, Duodenal, Colonic, Pulmonary (Airway) Stents, Urological Stents), End-use (Hospitals), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Vascular Stent Market by Technology (Dug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029 - Product Image

Vascular Stent Market by Technology (Dug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029

  • Report
  • 427 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.